Company Filing History:
Years Active: 2023-2025
Title: Zuoan Yi: Innovator in Immune Regulation
Introduction
Zuoan Yi is a prominent inventor based in Mountain View, CA (US). He has made significant contributions to the field of immunology, particularly through his innovative work on antibodies.
Latest Patents
Zuoan Yi holds 2 patents, with his latest invention focusing on Anti-CD96 antibodies and methods of use thereof. This patent provides binding proteins, such as antibodies and antigen-binding fragments, which specifically bind to the human CD96 receptor protein (hu-CD96). These antibodies are capable of decreasing, inhibiting, and/or fully blocking immune regulatory effects mediated by hu-CD96. The disclosure also outlines methods for using these antibodies to treat diseases and conditions that respond to the modulation of immune regulatory functions mediated by CD96 binding to CD155, including effects arising from CD96 interactions with CD226 and/or TIGIT.
Career Highlights
Zuoan Yi is currently employed at 23andMe, Inc., where he continues to advance his research and development in the field of immunology. His work has the potential to impact various therapeutic areas, particularly those related to immune regulation.
Collaborations
Some of his notable coworkers include Yu Chen and Chingwei Vivian Lee, who contribute to the collaborative environment at 23andMe, Inc.
Conclusion
Zuoan Yi's innovative work in the development of Anti-CD96 antibodies showcases his commitment to advancing medical science and improving therapeutic options for patients. His contributions are paving the way for future breakthroughs in immune regulation.